跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 269 条关于
“SDGR-8139”
全部
269
临床试验
145
药物
110
机构
1
资讯
13
9天前
Schrödinger Co-Founds Tectora Therapeutics with $55M Series A to Advance Immunology and Inflammation Programs
去年
Schrödinger to Present Phase 1 Data on MALT1 Inhibitor SGR-1505 for Relapsed/Refractory B-Cell Malignancies
去年
Schrödinger Reports 63% Revenue Growth in Q1 2025, Prepares to Share Clinical Data for SGR-1505
去年
Schrödinger Announces Strategic Priorities for 2025, Advances Clinical Programs
上个月
Bristol Myers Squibb Deploys Schrödinger's Bunsen AI Co-Scientist at Scale to Accelerate Drug Discovery
去年
Schrödinger Unveils Promising Preclinical Data for Novel Cancer Therapeutics at AACR 2025
去年
Symeres Acquires DGr Pharma to Strengthen Integrated Drug Development Services
去年
Schrödinger's SGR-1505 Receives FDA Fast Track Designation for Relapsed Waldenström Macroglobulinemia
9个月前
Zura Bio Advances Tibulizumab Phase 2 Trials with $139 Million Cash Runway Through 2027
5个月前
Vivani Medical Advances NPM-139 Semaglutide Implant Toward Phase 1 Trial Following Successful Preclinical Data
第 1 页,共 2 页
上一页
下一页